Corey Seager and Josh Jung are candidates for offseason surgery, Rangers announce

What happened

Texas Rangers shortstop Corey Seager and third baseman Josh Jung are both candidates for offseason surgery — Seager for an elbow issue, Jung for a hand issue — MLB.com reported. The club's announcement raises questions about whether either player will be ready for the start of next season, though no timetable has been attached to either situation and neither procedure has been described as scheduled or decided.

Two players. Two different body parts. One offseason that was already going to require significant attention from a front office that just watched its season end without October baseball.

Why it matters

The Rangers closed 2026 at 80-82, eliminated from postseason contention on the final day of the regular season. Rangers GM Chris Young publicly acknowledged organizational shortcomings and pledged to address the team's issues heading into the offseason, per reporting from earlier this week. That pledge now arrives with an immediate and concrete complication: the two players who anchor the left side of the infield — and represent a substantial portion of the franchise's long-term investment — are each facing the possibility of procedures that could compress or eliminate their normal spring preparation window.

The timing is worth sitting with. The Rangers did not make the postseason. There is no October schedule to navigate, no playoff roster to construct around partial availability. In that narrow sense, the calendar is cooperative — if surgery is going to happen, a team that is done playing has more runway than one still chasing a pennant. But an offseason procedure for either player shortens the lead time before spring training, and two simultaneous surgical candidacies on two cornerstone infielders is not the kind of roster arithmetic any front office draws up voluntarily.

The broader organizational picture matters here too. Seager missed 60 games for the second consecutive season in 2026, per earlier Posterior Wire reporting. That durability pattern was already a topic of concern heading into this offseason; the elbow surgery candidacy adds a new dimension to a conversation that was already underway before the final out of the regular season was recorded. Jung's hand situation arrives alongside it, meaning the Rangers enter their offseason planning without a clear health baseline for either of their two most prominent infield names.

Where the club stands

Texas finished 80-82 (.494), landing 2nd in the AL West, 1 game back in the division. Their Wild Card standing ranked 4th, sitting 4.0 games relative to the cut line — close enough to have felt relevant through stretches of September, not close enough to matter when the final day arrived. The club enters the offseason on a one-game losing streak, having been eliminated from both the division race and the Wild Card race.

The Rangers are done for 2026. The 80-82 record and the AL West's second-place finish are the final entries in a season that ended without October baseball. GM Chris Young's public acknowledgment of the team's issues — reported in the days surrounding the elimination — sets the organizational tone heading into what figures to be an active offseason. The surgery candidacies for Seager and Jung now sit at the center of whatever roster planning follows.

It is a front office that has signaled intent to act and now must act with incomplete information about two of its most important players. The health status of the infield's two most prominent names will shape what moves are available, what needs to be addressed externally, and how aggressively the club can pursue any given direction.

What we don't know yet

Neither surgery has been described as scheduled or decided. Both players are characterized as candidates, which means the procedures remain possibilities rather than certainties at the time of MLB.com's report. No timetable has been provided for either player's potential return, and no diagnosis beyond the affected body part — elbow for Seager, hand for Jung — appears in the reporting.

The practical questions that flow from that uncertainty are significant. An offseason surgery early in the calendar leaves more recovery time than one scheduled later. A procedure that does not happen leaves a player with a full spring. The Rangers and their medical staff presumably have a clearer picture than what has been made public, but that picture has not been shared, and the desk will not fill in the gaps.

What is known is that Seager's elbow candidacy lands on top of a durability record that already drew organizational attention — 60 games missed for the second straight season, per earlier Posterior Wire reporting. Whether the elbow issue is connected to that broader pattern has not been reported.

What to watch

The first thing to watch is whether either surgery moves from candidacy to decision, and when. An announcement that a procedure has been scheduled would materially change the calculus around each player's spring availability and, by extension, the Rangers' offseason priorities. The second is how the front office responds in the broader context — GM Young has signaled intent to address the roster, and the health status of Seager and Jung will determine how much of that work needs to account for infield depth, timeline flexibility, or both.

A week removed from the end of the regular season, Nicky Lopez also exited a Rangers game with a left ankle/heel injury, per earlier Posterior Wire reporting, adding a third infield health note to an already crowded offseason medical file. Whether that situation requires any further attention has not been reported.

The desk will update as the Rangers provide further clarity on Seager and Jung.